This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Translational Prostate Cancer
        • Women in Science
          Andrea Miyahira, Ph.D
        • Health Policy
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
    • Trials in Progress
      • DORA - PCCTC
      • IRONMAN - PCCTC
      • PROMISE - PCCTC
      • SPLASH Trial
      • Oral EPI-7386
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2022
      • ASCO GU 2023
      • EAU 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology
  4. Prostate Cancer

Conferences

Recent Abstracts
SUO 2016: Limiting overuse in asympomatic microhematuria evaluation, is there a safe way forward? - Session Highlights December 2, 2016
SUO 2016: Management of Residual Retroperitoneal Masses after Chemotherapy for Advanced Seminoma - Session Highlights December 1, 2016
SUO 2016: Anatomic Considerations for Nerve-Sparing RPLND - Session Highlights December 1, 2016
SUO 2016: Pitfalls in GCT Management: Urology - Session Highlights December 1, 2016
SUO 2016: Common pitfalls in the management of germ cell tumors: Medical Oncology - Session Highlights December 1, 2016
SUO 2016: SUO-CTC Session - Session Highlights December 1, 2016
SUO 2016: Challenging cases - Session Highlights December 1, 2016
SUO 2016: Role of salvage therapy in M0 CSPC - Session Highlights December 1, 2016
SUO 2016: Genomic classification of non-clear cell kidney cancer and implications for clinical management - Session Highlights December 1, 2016
SUO 2016: Novel Immune Approaches to Muscle Invasive Bladder Cancer - Session Highlights December 1, 2016
SUO 2016: Role of Definite Therapy in Oligometastatic Disease - Session Highlights December 1, 2016
SUO 2016: Novel Immune Approaches for High Risk Non-muscle Invasive Bladder Cancer - Session Highlights December 1, 2016
SUO 2016: Targeted approaches for T1 bladder cancer - Session Highlights December 1, 2016
SUO 2016: Role of Chemotherapy in Oligometastatic Disease - Session Highlights December 1, 2016
SUO 2016: Imaging Modalities to Detect Metastatic Disease - Session Highlights December 1, 2016
SUO 2016: Renal Dysfunction and the Kidney Cancer Patient - Session Highlights December 1, 2016
SUO 2016: State of the Art lecture: Genomic profiling and clinical implications of atypical intermediate prostate cancer phenotype - Session Highlights December 1, 2016
SUO 2016: Factors Predicting Skeletal-Related Events in Patients with Bone Metastatic Castration-Resistant Prostate Cancer - Poster Session Highlights December 1, 2016
SUO 2016: Percutaneous Biopsy of Renal Masses and the Role in Kidney Cancer Management - Session Highlights December 1, 2016
SUO 2016: Addressing patient expectations - Session Highlights December 1, 2016
Page 409 of 507
  • Start
  • Prev
  • 404
  • 405
  • 406
  • 407
  • 408
  • 409
  • 410
  • 411
  • 412
  • 413
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free